Ru-Tian Li (Rutian Li)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Inflammatory Response

Monoclonal Antibody

Top Venues

Future oncology (London, England)

Journal of gastroenterology and hepatology

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)
Yu-Chen Ge, Li-Mei Min, Qin Liu, Xiao-Lu Wang, Shou-Feng Wang, Jun Chen, Wen-Tao Kong, Su-Jia Wu, Guang-Xin Zhou, Ting-Ting Wang, Bao-Rui Liu, Ru-Tian Li
Neo-adjuvant radiation and intratumoral immunotherapy followed by surgery- NARIS trial for extremity soft tissue sarcoma. Future oncology (London, England) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)
Xinyue Wang, Fanyan Meng, Xiang Li, Luxin Xue, Anni Chen, Yuling Qiu, Zhifan Zhang, Lin Li, Fengcen Liu, Yishan Li, Zhichen Sun, Yanhong Chu, Ruihan Xu, Lixia Yu, Jie Shao, Manman Tian, Xiaoping Qian, Qin Liu, Baorui Liu, Ru-Tian Li
Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Fangcen Liu, Qin Wang, Yishan Li, Lin Li, Jiaochun Shi, Xiangshan Fan, Qiuyue Pan, Ru-Tian Li
KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients. Journal of gastroenterology and hepatology (2023)
Fangcen Liu, Qin Wang, Yishan Li, Lin Li, Jiaochun Shi, Xiangshan Fan, Qiuyue Pan, Ru-Tian Li
KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients. Journal of gastroenterology and hepatology (2023)
Yuling Qiu, Xuedi Wang, Yingrui Fan, Yanru Bao, Fanqing Meng, Baorui Liu, Ru-Tian Li
A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next-generation sequencing prospect. Thoracic cancer (2023)
Xinyue Wang, Fanyan Meng, Xiang Li, Luxin Xue, Anni Chen, Yuling Qiu, Zhifan Zhang, Lin Li, Fengcen Liu, Yishan Li, Zhichen Sun, Yanhong Chu, Ruihan Xu, Lixia Yu, Jie Shao, Manman Tian, Xiaoping Qian, Qin Liu, Baorui Liu, Ru-Tian Li
Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Chun Wang, Yuanhao Jing, Wenting Yu, Jie Gu, Zijian Wei, Anni Chen, Ying-Tzu Yen, Xiaowen He, Lanqi Cen, Aoxing Chen, Xueru Song, Yirong Wu, Lixia Yu, Gaojian Tao, Baorui Liu, Shoufeng Wang, Bin Xue, Ru-Tian Li
Bivalent Gadolinium Ions Forming Injectable Hydrogels for Simultaneous in Situ Vaccination Therapy and Imaging of Soft Tissue Sarcoma. Advanced healthcare materials (2023)
Qin Wang, Ying-Tzu Yen, Chen Xie, Fangcen Liu, Qin Liu, Jia Wei, Lixia Yu, Lifeng Wang, Fanyan Meng, Ru-Tian Li, Baorui Liu
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells. Drug delivery 28 (1) (2021)